Intermountain Healthcare Innovation Fund, the investment arm of care provider Intermountain Healthcare, has invested $1m in US-based digital healthcare integration software producer Redox, taking its series B round to $10m.
The round was led by venture capital firm RRE Ventures and included healthcare seed fund HealthX Ventures and VC firms .406 Ventures, Flybridge Capital Partners and Dreamit Ventures.
Redox has developed an integration platform for healthcare applications, helping them interoperate with electronic health records within larger healthcare systems such as Intermountain.
Intermountain Healthcare Innovation Fund is managed by Healthbox, the healthcare-focused accelerator that hosted Redox as part of its 2015 Healthbox Studio program.
Vivek Reddy, chief health information officer of Intermountain Healthcare, said: “Redox is quickly becoming a standard in application interoperability.
“Their platform has evolved into the largest network of enterprise healthcare applications with the ability to scale innovations across large health systems like ours.”
The series B round follows a $3.5m series A led by .406 Ventures in October 2015 that also featured Flybridge Capital Partners and HealthX Ventures. Redox had raised $350,000 in seed capital the previous year, according to a regulatory filing.